NO20033624L - Matrise genekspresjon i chondrogenese - Google Patents

Matrise genekspresjon i chondrogenese

Info

Publication number
NO20033624L
NO20033624L NO20033624A NO20033624A NO20033624L NO 20033624 L NO20033624 L NO 20033624L NO 20033624 A NO20033624 A NO 20033624A NO 20033624 A NO20033624 A NO 20033624A NO 20033624 L NO20033624 L NO 20033624L
Authority
NO
Norway
Prior art keywords
chondrogenesis
gene expression
matrix gene
matrix
expression
Prior art date
Application number
NO20033624A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033624D0 (no
Inventor
Rebecca Roubin
Peter Ghosh
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sydney filed Critical Univ Sydney
Publication of NO20033624D0 publication Critical patent/NO20033624D0/no
Publication of NO20033624L publication Critical patent/NO20033624L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20033624A 2001-02-15 2003-08-14 Matrise genekspresjon i chondrogenese NO20033624L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR3116A AUPR311601A0 (en) 2001-02-15 2001-02-15 Matrix gene expression in chondrogenesis
PCT/AU2002/000163 WO2002064625A1 (en) 2001-02-15 2002-02-15 Matrix gene expression in chondrogenesis

Publications (2)

Publication Number Publication Date
NO20033624D0 NO20033624D0 (no) 2003-08-14
NO20033624L true NO20033624L (no) 2003-10-10

Family

ID=3827137

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033624A NO20033624L (no) 2001-02-15 2003-08-14 Matrise genekspresjon i chondrogenese

Country Status (8)

Country Link
US (1) US20040157329A1 (https=)
EP (1) EP1370579A4 (https=)
JP (1) JP2004537274A (https=)
AU (1) AUPR311601A0 (https=)
CA (1) CA2440743A1 (https=)
NO (1) NO20033624L (https=)
NZ (1) NZ528202A (https=)
WO (1) WO2002064625A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004026944D1 (de) * 2003-03-28 2010-06-10 Fujifilm Mfg Europe Bv RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
CN1838968A (zh) 2003-08-08 2006-09-27 艾伯吉尼斯公司 针对甲状旁腺激素(pth)之抗体和其用途
WO2005106495A1 (en) * 2004-05-04 2005-11-10 Pharmacia & Upjohn Company Llc Procollagen ii biomarkers and methods
US20080082170A1 (en) * 2006-09-29 2008-04-03 Peterman Marc M Apparatus and methods for surgical repair
ES2678211T3 (es) 2012-03-27 2018-08-09 Ventana Medical Systems, Inc. Conjugados de señalización y procedimientos de uso
WO2014093836A1 (en) * 2012-12-13 2014-06-19 University Of Georgia Research Foundation, Inc. Ossification-inducing composition and methods of use thereof
JP2020502056A (ja) * 2016-11-13 2020-01-23 イマジン ファーマ 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法
US20230210942A1 (en) * 2018-01-09 2023-07-06 Imagine Pharma Llc Methods and compositions for modulating endothelial cell dysfunction
CN113096736B (zh) * 2021-03-26 2023-10-31 北京源生康泰基因科技有限公司 一种基于纳米孔测序的病毒实时自动分析方法及系统
CN113201487A (zh) * 2021-07-06 2021-08-03 广东先康达生物科技有限公司 成软骨细胞培养基及成软骨细胞的培养方法
CN113563458B (zh) * 2021-07-19 2023-07-21 嘉兴恒杰生物制药股份有限公司 一种非变性ii型胶原蛋白的制备方法
JP2024532985A (ja) * 2021-09-22 2024-09-12 イマジン ファーマ、エルエルシー １型糖尿病患者膵臓組織からインスリンおよびグルカゴン分泌細胞を増殖させるための組成物および方法およびその治療的使用
CN119504941B (zh) * 2024-12-03 2026-01-13 中国海洋大学 一种富含海洋肽钙螯合物的骨健康压片糖果及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080891A (en) * 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US6159464A (en) * 1990-12-20 2000-12-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints
JP2001512013A (ja) * 1997-08-01 2001-08-21 ジェンセット 前立腺に発現される分泌タンパク質の５’ｅｓｔ
US20030144475A1 (en) * 1999-12-06 2003-07-31 Seishi Kato Human protein and cdna

Also Published As

Publication number Publication date
AUPR311601A0 (en) 2001-03-08
EP1370579A4 (en) 2005-05-11
EP1370579A1 (en) 2003-12-17
WO2002064625A1 (en) 2002-08-22
US20040157329A1 (en) 2004-08-12
NZ528202A (en) 2005-09-30
JP2004537274A (ja) 2004-12-16
CA2440743A1 (en) 2002-08-22
NO20033624D0 (no) 2003-08-14

Similar Documents

Publication Publication Date Title
DE60203994D1 (de) Matrixsteckverbinder
EP1497655A4 (en) IMPROVED GENE EXPRESSION SYSTEM
DK1391502T3 (da) Værtsmikroorganismer
DE60212066D1 (de) Abgabespritze
AU2002306374A1 (en) Genes with ES cell-specific expression
NO20033624L (no) Matrise genekspresjon i chondrogenese
EP1490074A4 (en) MIXED CELLULAR GENE THERAPY
EP1142591A4 (en) gene carriers
DK1689869T3 (da) Rekombinant mikroorganisme
EE200400080A (et) Stendid
DE60114022D1 (de) Matrix metalloproteinase-inhibitoren
DE602004022022D1 (de) Dilatationsvorrichtung
AU2001270478A1 (en) Gene expression in biological conditions
DE60211549D1 (de) Geformte zuleitung mit elektroden
FI20001004A0 (fi) Sovitelma taajuusmuuttajassa
GB0122232D0 (en) Gene expression
DE60305270D1 (de) Schreibgerät
NO20022148D0 (no) Ikke-viralt genleveringssystem
DE60305415D1 (de) Schreibgerät
DK1680502T3 (da) Rekombinant mikroorganisme
EP1428891A4 (en) NEDL-1, A NEW GENE
FI20011441A7 (fi) Levitysjärjestely
AU2003275946A1 (en) Gene expression in biological conditions
NO20043613L (no) Genetisk polymorfi i preprotachykiningenet
DE60312585D1 (de) Zierband

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application